Autoantibodies and cancer among asbestos-exposed cohorts in Western Australia

References

• Abu-Shakra, M., D. Buskila, M. Ehrenfeld, K. Conrad, and Y. Shoenfeld. 2001. Cancer and autoimmunity: Autoimmune and rheumatic features in patients with malignancies. Ann. Rheum. Dis. 60:433–40. doi:10.1136/ard.60.5.433.
   PubMed Web of Science ®Google Scholar
• Armstrong, B. K., N. H. Deklerk, A. W. Musk, and M. S. T. Hobbs. 1988. Mortality in miners and millers of crocidolite in Western Australia. Br. J. Ind. Med. 45:5–13.
   PubMedGoogle Scholar
• Azrielant, S., S. Tiosano, A. Watad, N. Mahroum, A. Whitby, D. Comaneshter, A. D. Cohen, and H. Amital. 2017. Correlation between systemic lupus erythematosus and malignancies: A cross-sectional population-based study. Immunol. Res. 65:464–69. doi:10.1007/s12026-016-8885-8.
   PubMed Web of Science ®Google Scholar
• Betteridge, Z. E., L. Priest, R. G. Cooper, N. J. McHugh, F. Blackhall, and J. A. Lamb. 2018. Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer. Arthritis Res. Ther. 20. doi:10.1186/s13075-018-1678-9.
   PubMed Web of Science ®Google Scholar
• Bockle, B. C., G. Stanarevic, G. Ratzinger, and N. T. Sepp. 2012. Analysis of 303 Ro/SS-A antibody-positive patients: Is this antibody a possible marker for malignancy? Br. J. Dermatol. 167:1067–75. doi:10.1111/j.1365-2133.2012.11161.x.
   PubMed Web of Science ®Google Scholar
• Borelli, V., E. Trevisan, V. Francesca, and G. Zabucchi. 2018. The secretory response of rat peritoneal mast cells on exposure to mineral fibers. Int. J. Environ. Res. Public Health 15. doi:10.3390/ijerph15010104.
   Web of Science ®Google Scholar
• Bunderson-Schelvan, M., J. C. Pfau, R. Crouch, and A. Holian. 2011. Nonpulmonary outcomes of asbestos exposure. J. Toxicol. Environ. Health B 14:122–52. doi:10.1080/10937404.2011.556048.
   PubMed Web of Science ®Google Scholar
• Ceribelli, A., M. Fredi, M. Taraborelli, I. Cavazzana, F. Franceschini, M. Quinzanini, A. Tincani, S. J. Ross, J. Y. F. Chan, B. A. Pauley, et al. 2012. Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. Arthritis Res. Ther. 14. doi:10.1186/ar3822.
   Web of Science ®Google Scholar
• Chapman, C. J., A. Murray, J. E. McElveen, U. Sahin, U. Luxemburger, O. Tureci, R. Wiewrodt, A. C. Barnes, and J. F. Robertson. 2008. Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure. Thorax 63:228–33. doi:10.1136/thx.2007.083592.
   PubMed Web of Science ®Google Scholar
• Creaney, J., I. M. Dick, A. W. Musk, N. J. Olsen, and B. W. Robinson. 2016. Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers. Biomarkers 21:551–61. doi:10.3109/1354750X.2016.1160429.
   PubMed Web of Science ®Google Scholar
• Diegel, R., B. Black, J. C. Pfau, T. McNew, C. Noonan, and R. Flores. 2018. Case series: Rheumatological manifestations attributed to exposure to libby asbestiform amphiboles. J. Toxicol. Environ. Health Part A 81:734–47. doi:10.1080/15287394.2018.1485124.
   PubMed Web of Science ®Google Scholar
• Dinse, G. E., T. A. Jusko, I. Z. Whitt, C. A. Co, C. G. Parks, M. Satoh, E. K. L. Chan, K. M. Rose, N. J. Walker, L. S. Birnbaum, et al. 2016. Associations between selected xenobiotics and antinuclear antibodies in the NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEy, 1999-2004. Environ. Health Perspect. 124:426–36. doi:10.1289/ehp.1409345.
   PubMed Web of Science ®Google Scholar
• Dinse, G. E., C. G. Parks, C. R. Weinberg, C. A. Co, J. Wilkerson, D. C. Zeldin, E. K. L. Chan, and F. W. Miller. 2020. Increasing prevalence of antinuclear antibodies in the United States. Arthritis Rheumatol. 72:1026–35. doi:10.1002/art.41214.
   PubMed Web of Science ®Google Scholar
• Ferro, A., C. N. Zebedeo, C. Davis, K. W. Ng, and J. C. Pfau. 2014. Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. J Immunotoxicol 11:283–90. doi:10.3109/1547691X.2013.847510.
   PubMed Web of Science ®Google Scholar
• Fiorentino, D. F., L. S. Chung, L. Christopher-Stine, L. Zaba, S. F. Li, A. L. Mammen, A. Rosen, and L. Casciola-Rosen. 2013. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1 gamma. Arthritis Rheum-Us 65:2954–62. doi:10.1002/art.38093.
   PubMed Web of Science ®Google Scholar
• Garcia-De La Torre, I. 2015. Clinical usefulness of autoantibodies in idiopathic inflammatory myositis. Front. Immunol. 6:331. doi:10.3389/fimmu.2015.00331.
   PubMed Web of Science ®Google Scholar
• Giat, E., M. Ehrenfeld, and Y. Shoenfeld. 2017. Cancer and autoimmune diseases. Autoimmun. Rev. 16:1049–57. doi:10.1016/j.autrev.2017.07.022.
   PubMed Web of Science ®Google Scholar
• Igusa, T., L. K. Hummers, K. Visvanathan, C. Richardson, F. M. Wigley, L. Casciola-Rosen, A. Rosen, and A. A. Shah. 2018. Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Ann. Rheum. Dis. 77:1180–87. doi:10.1136/annrheumdis-2018-212999.
   Web of Science ®Google Scholar
• Kamei, M., M. Kato, K. Mochizuki, K. Kuroda, S. Sato, S. Hashizume, K. Yasumoto, H. Murakami, and K. Nomoto. 1992. Serodiagnosis of cancers by Elisa of antihistone H2b antibody. Biother. 4:17–22. doi:10.1007/Bf02171705.
   PubMedGoogle Scholar
• Kato, M., K. Mochizuki, K. Kuroda, S. Sato, H. Murakami, K. Yasumoto, K. Nomoto, and S. Hashizume. 1991. Histone H2B as an antigen recognized by lung cancer-specific human monoclonal antibody HB4C5. Hum. Antibodies Hybridomas 2:94–101.
   PubMedGoogle Scholar
• Klebe, S., J. Leigh, D. W. Henderson, and M. Nurminen. 2019. Asbestos, smoking and lung cancer: An update. Int. J. Environ. Res. Public Health 17. doi:10.3390/ijerph17010258.
   Web of Science ®Google Scholar
• Lee, F., and D. A. Lawrence. 2018. From infections to anthropogenic inflicted pathologies: Involvement of immune balance. J. Toxicol. Environ. Health B 21:24–46. doi:10.1080/10937404.2017.1412212.
   PubMed Web of Science ®Google Scholar
• Li, Q. Z., D. R. Karp, J. X. Quan, V. K. Branch, J. C. Zhou, Y. Lian, B. F. Chong, E. K. Wakeland, and N. J. Olsen. 2011. Risk factors for ANA positivity in healthy persons. Arthritis Res. Ther. 13. doi:10.1186/ar3271.
   Web of Science ®Google Scholar
• Liu, D., W. B. Qian, D. L. Li, and L. J. Kong. 2018. Ro60/SSA levels are increased and promote the progression of pancreatic ductal adenocarcinoma. Biochem. Biophys. Res. Commun. 495:2519–24. doi:10.1016/j.bbrc.2017.12.124.
   PubMed Web of Science ®Google Scholar
• Macdonald, I. K., C. B. Parsy-Kowalska, and C. J. Chapman. 2017. Autoantibodies: Opportunities for early cancer detection. Trends Cancer 3:198–213. doi:10.1016/j.trecan.2017.02.003.
   PubMed Web of Science ®Google Scholar
• Nagai, H., T. Ishihara, W. H. Lee, H. Ohara, Y. Okazaki, K. Okawa, and S. Toyokuni. 2011. Asbestos surface provides a niche for oxidative modification. Cancer Sci. 102:2118–25. doi:10.1111/j.1349-7006.2011.02087.x.
   PubMed Web of Science ®Google Scholar
• Ngo, S. T., F. J. Steyn, and P. A. McCombe. 2014. Gender differences in autoimmune disease. Front Neuroendocrinol. 35:347–69. doi:10.1016/j.yfrne.2014.04.004.
   PubMed Web of Science ®Google Scholar
• Noble, P. W., S. Bernatsky, A. E. Clarke, D. A. Isenberg, R. Ramsey-Goldman, and J. E. Hansen. 2016. DNA-damaging autoantibodies and cancer: The lupus butterfly theory. Nat. Rev. Rheumatol. 12:429–34. doi:10.1038/nrrheum.2016.23.
   PubMed Web of Science ®Google Scholar
• Noonan, C. W., J. C. Pfau, T. C. Larson, and M. R. Spence. 2006. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health Perspect. 114:1243–47. doi:10.1289/ehp.9203.
   PubMed Web of Science ®Google Scholar
• Palterer, B., G. Vitiello, A. Carraresi, M. G. Giudizi, D. Cammelli, and P. Parronchi. 2018. Bench to bedside review of myositis autoantibodies. Clin. Mol. Allergy 16:5. doi:10.1186/s12948-018-0084-9.
   PubMedGoogle Scholar
• Parker, J. C., R. W. Burlingame, T. T. Webb, and C. C. Bunn. 2008. Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA. Rheumatol 47:976–79. doi:10.1093/rheumatology/ken201.
   PubMed Web of Science ®Google Scholar
• Pernis, B., E. C. Vigliani, and I. J. Selikoff. 1965. Rheumatoid factor in serum of individuals exposed to asbestos. Ann. N. Y. Acad. Sci. 132:112–20. doi:10.1111/j.1749-6632.1965.tb41094.x.
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., C. Barbour, B. Black, K. M. Serve, and M. J. Fritzler. 2018. Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts. J. Toxicol. Environ. Health Part A 81:1015–27. doi:10.1080/15287394.2018.1512432.
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., T. McNew, K. Hanley, L. Swan, and B. Black. 2019. Autoimmune markers for progression of libby amphibole lamellar pleural thickening. Inhal. Toxicol. 31:409–19. doi:10.1080/08958378.2019.1699616.
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., J. J. Sentissi, G. Weller, and E. A. Putnam. 2005. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health Perspect. 113:25–30. doi:10.1289/ehp.7431.
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., K. M. Serve, and C. W. Noonan. 2014. Autoimmunity and asbestos exposure. Autoimmun. Dis. 782045. doi:10.1155/2014/782045.
   PubMedGoogle Scholar
• Pollard, K. M. 2012. Gender differences in autoimmunity associated with exposure to environmental factors. J. Autoimmun. 38:J177–J186. doi:10.1016/j.jaut.2011.11.007.
   PubMed Web of Science ®Google Scholar
• Reid, A., P. Franklin, N. de Klerk, J. Creaney, F. Brims, B. Musk, and J. Pfau. 2018. Autoimmune antibodies and asbestos exposure: Evidence from Wittenoom, Western Australia. Am. J. Ind. Med. 61:615–20. doi:10.1002/ajim.22863.
   PubMed Web of Science ®Google Scholar
• Robinson, C., M. Callow, S. Stevenson, B. Scott, B. W. Robinson, and R. A. Lake. 2000. Serologic responses in patients with malignant mesothelioma: Evidence for both public and private specificities. Am. J. Respir. Cell Mol. Biol. 22:550–56. doi:10.1165/ajrcmb.22.5.3930.
   PubMed Web of Science ®Google Scholar
• Rosen, A., and L. Casciola-Rosen. 1999. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6:6–12. doi:10.1038/sj.cdd.4400460.
   PubMed Web of Science ®Google Scholar
• Satoh, M., E. K. Chan, L. A. Ho, K. M. Rose, C. G. Parks, R. D. Cohn, T. A. Jusko, N. J. Walker, D. R. Germolec, I. Z. Whitt, et al. 2012. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheumatol. 64:2319–27. doi:10.1002/art.34380.
   PubMed Web of Science ®Google Scholar
• Solomon, D. H., A. J. Kavanaugh, and P. H. Schur, Guidelines American College of Rheumatology Ad Hoc Committee on Immunologic Testing. 2002. Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing. Arthritis Rheumatol. 47: 434–44. doi: 10.1002/art.10561.
   PubMed Web of Science ®Google Scholar
• Tan, E. M. 2012. Autoantibodies, autoimmune disease, and the birth of immune diagnostics. J. Clin. Invest. 122:3835–36. doi:10.1172/JCI66510.
   PubMed Web of Science ®Google Scholar
• Tukey, J. W. 1977. Exploratory data analysis. Reading, MA: Addison-Wesley Publishing.
   Google Scholar
• Valencia, J. C., N. Egbukichi, and R. A. Erwin-Cohen. 2019. Autoimmunity and cancer, the paradox comorbidities challenging therapy in the context of preexisting autoimmunity. J. Interf. Cytok. Res. 39:72–84. doi:10.1089/jir.2018.0060.
   PubMed Web of Science ®Google Scholar
• Vlagea, A., S. Falagan, G. Gutierrez-Gutierrez, J. Moreno-Rubio, M. Merino, F. Zambrana, E. Casado, and M. Sereno. 2018. Antinuclear antibodies and cancer: A literature review. Crit. Rev. Oncol. Hematol. 127:42–49. doi:10.1016/j.critrevonc.2018.05.002.
   PubMed Web of Science ®Google Scholar
• Zhang, X., W. Shen, X. Dong, J. Fan, L. Liu, X. Gao, K. H. Kernstine, and L. Zhong. 2013. Identification of novel autoantibodies for detection of malignant mesothelioma. PLoS One 8:e72458. doi:10.1371/journal.pone.0072458.
   PubMed Web of Science ®Google Scholar